A European medical review of recent studies concludes that widely used sugar substitutes may reshape gut microbiome communities and produce metabolic shifts resembling those seen with caloric sweeteners. The review consolidates observational and experimental work indicating that diet-product alternatives are not metabolically inert.
Researchers highlighted shifts in bacterial populations linked to glucose handling and inflammation markers in study participants consuming non-caloric sweeteners over extended periods. Clinicians said the results complicate long-standing assumptions that switching from sugar to substitutes automatically improves metabolic health for all consumers.
Food industry representatives note that regulatory bodies in multiple jurisdictions continue to classify approved sweeteners as safe at typical intake levels. Medical authors nonetheless called for clearer labeling and guidance for patients with diabetes, obesity, or irritable bowel conditions who may respond differently.
Nutrition scientists stressed that individual microbiome variation makes population-wide predictions difficult without personalized testing. Public health agencies may weigh whether dietary guidelines should distinguish between types of substitutes rather than treating them as a single category.
Further longitudinal studies are expected to examine whether observed microbiome disruptions translate into clinically significant disease risk over years of regular consumption.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.medscape.com/